412 related articles for article (PubMed ID: 28922426)
21. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice.
Bereczky S; Lindegren G; Karlberg H; Akerström S; Klingström J; Mirazimi A
J Gen Virol; 2010 Jun; 91(Pt 6):1473-7. PubMed ID: 20164263
[TBL] [Abstract][Full Text] [Related]
22. Single-dose replicon particle vaccine provides complete protection against Crimean-Congo hemorrhagic fever virus in mice.
Scholte FEM; Spengler JR; Welch SR; Harmon JR; Coleman-McCray JD; Freitas BT; Kainulainen MH; Pegan SD; Nichol ST; Bergeron É; Spiropoulou CF
Emerg Microbes Infect; 2019; 8(1):575-578. PubMed ID: 30947619
[No Abstract] [Full Text] [Related]
23. Crimean-Congo Hemorrhagic Fever Mouse Model Recapitulating Human Convalescence.
Hawman DW; Meade-White K; Haddock E; Habib R; Scott D; Thomas T; Rosenke R; Feldmann H
J Virol; 2019 Sep; 93(18):. PubMed ID: 31292241
[TBL] [Abstract][Full Text] [Related]
24. Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.
Bertolotti-Ciarlet A; Smith J; Strecker K; Paragas J; Altamura LA; McFalls JM; Frias-Stäheli N; García-Sastre A; Schmaljohn CS; Doms RW
J Virol; 2005 May; 79(10):6152-61. PubMed ID: 15858000
[TBL] [Abstract][Full Text] [Related]
25. Adenoviral vectored vaccination protects against Crimean-Congo Haemorrhagic Fever disease in a lethal challenge model.
Saunders JE; Gilbride C; Dowall S; Morris S; Ulaszewska M; Spencer AJ; Rayner E; Graham VA; Kennedy E; Thomas K; Hewson R; Gilbert SC; Belij-Rammerstorfer S; Lambe T
EBioMedicine; 2023 Apr; 90():104523. PubMed ID: 36933409
[TBL] [Abstract][Full Text] [Related]
26. GEM-PA-Based Subunit Vaccines of Crimean Congo Hemorrhagic Fever Induces Systemic Immune Responses in Mice.
Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Bi J; Jiao C; Li E; Wang T; Wang J; Jin H; Huang P; Yan F; Yang S; Xia X
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016285
[TBL] [Abstract][Full Text] [Related]
27. Convalescent human plasma candidate reference materials protect against Crimean-Congo haemorrhagic fever virus (CCHFV) challenge in an A129 mouse model.
Kempster S; Hassall M; Graham V; Kennedy E; Findlay-Wilson S; Salguero FJ; Bagci B; Elaldi N; Oz M; Tasseten T; Charlton FW; Barr JN; Fontana J; Duru C; Ezeajughi E; Matejtschuk P; Arnold U; Adedeji Y; Mirazimi A; Hewson R; Dowall S; Almond N
Virus Res; 2024 Aug; 346():199409. PubMed ID: 38815869
[TBL] [Abstract][Full Text] [Related]
28. Identification of broadly neutralizing monoclonal antibodies against Crimean-Congo hemorrhagic fever virus.
Zivcec M; Guerrero LIW; Albariño CG; Bergeron É; Nichol ST; Spiropoulou CF
Antiviral Res; 2017 Oct; 146():112-120. PubMed ID: 28842265
[TBL] [Abstract][Full Text] [Related]
29. Healthy individuals' immune response to the Bulgarian Crimean-Congo hemorrhagic fever virus vaccine.
Mousavi-Jazi M; Karlberg H; Papa A; Christova I; Mirazimi A
Vaccine; 2012 Sep; 30(44):6225-9. PubMed ID: 22902680
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of a Modified Vaccinia Ankara-based vaccine candidate against Crimean-Congo Haemorrhagic Fever virus require both cellular and humoral responses.
Dowall SD; Graham VA; Rayner E; Hunter L; Watson R; Taylor I; Rule A; Carroll MW; Hewson R
PLoS One; 2016; 11(6):e0156637. PubMed ID: 27272940
[TBL] [Abstract][Full Text] [Related]
31. Fine mapping epitope on glycoprotein Gc from Crimean-Congo hemorrhagic fever virus.
Zhang J; Simayi A; Wang M; Moming A; Xu W; Wang C; Li Y; Ding J; Deng F; Zhang Y; Sun S
Comp Immunol Microbiol Infect Dis; 2019 Dec; 67():101371. PubMed ID: 31627038
[TBL] [Abstract][Full Text] [Related]
32. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
Boshra H; Lorenzo G; Rodriguez F; Brun A
Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
[TBL] [Abstract][Full Text] [Related]
33. Lethal Crimean-Congo hemorrhagic fever virus infection in interferon α/β receptor knockout mice is associated with high viral loads, proinflammatory responses, and coagulopathy.
Zivcec M; Safronetz D; Scott D; Robertson S; Ebihara H; Feldmann H
J Infect Dis; 2013 Jun; 207(12):1909-21. PubMed ID: 23417661
[TBL] [Abstract][Full Text] [Related]
34. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
35. The Bulgarian vaccine Crimean-Congo haemorrhagic fever virus strain.
Papa A; Papadimitriou E; Christova I
Scand J Infect Dis; 2011 Mar; 43(3):225-9. PubMed ID: 21142621
[TBL] [Abstract][Full Text] [Related]
36. Mice orally immunized with a transgenic plant expressing the glycoprotein of Crimean-Congo hemorrhagic fever virus.
Ghiasi SM; Salmanian AH; Chinikar S; Zakeri S
Clin Vaccine Immunol; 2011 Dec; 18(12):2031-7. PubMed ID: 22012978
[TBL] [Abstract][Full Text] [Related]
37. Accelerated DNA vaccine regimen provides protection against Crimean-Congo hemorrhagic fever virus challenge in a macaque model.
Hawman DW; Meade-White K; Leventhal S; Appelberg S; Ahlén G; Nikouyan N; Clancy C; Smith B; Hanley P; Lovaglio J; Mirazimi A; Sällberg M; Feldmann H
Mol Ther; 2023 Feb; 31(2):387-397. PubMed ID: 36184852
[TBL] [Abstract][Full Text] [Related]
38. Establishment of two serological methods for detecting IgG and neutralizing antibodies against Crimean-Congo hemorrhagic fever virus glycoprotein.
Wang Q; Wang S; Shi Z; Li Z; Zhao Y; Feng N; Wang T; Yan F; Xia X
Front Cell Infect Microbiol; 2024; 14():1341332. PubMed ID: 38746783
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in understanding Crimean-Congo hemorrhagic fever virus.
Hawman DW; Feldmann H
F1000Res; 2018; 7():. PubMed ID: 30416710
[TBL] [Abstract][Full Text] [Related]
40. Human Polyclonal Antibodies Produced through DNA Vaccination of Transchromosomal Cattle Provide Mice with Post-Exposure Protection against Lethal Zaire and Sudan Ebolaviruses.
Bounds CE; Kwilas SA; Kuehne AI; Brannan JM; Bakken RR; Dye JM; Hooper JW; Dupuy LC; Ellefsen B; Hannaman D; Wu H; Jiao JA; Sullivan EJ; Schmaljohn CS
PLoS One; 2015; 10(9):e0137786. PubMed ID: 26422247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
